secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-09-19T23:59:59+00:00
Accession:  0001213900-25-089615
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology doubles share reserve to 30M under 2024 equity plan; issues 360K warrants
--------------------------------------------------------------------------------

- Board approved amendment to 2024 Omnibus Stock Incentive Plan, increasing authorized shares from 15M to 30M.
- Issued warrants to purchase 360K shares of common stock at $2.1875, exercisable March 10, 2026, expiring 2031.
- Warrants issued in private placement under Section 4(a)(2) to a financial advisor.
- No other changes were made to the 2024 Plan besides the share increase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025089615/0001213900-25-089615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025089615/ea0257909-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-089615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer